[
  {
    "ts": "2025-11-12T05:36:31+00:00",
    "headline": "The 5 Most Interesting Analyst Questions From Cencora’s Q3 Earnings Call",
    "summary": "Cencora’s third quarter saw a positive market response, as the company delivered revenue and non-GAAP earnings that exceeded Wall Street expectations. Management pointed to strong growth in its U.S. Healthcare Solutions segment and the contribution of specialty pharmaceuticals as key drivers. CEO Robert Mauch emphasized that investments in areas like specialty distribution and recent acquisitions, such as Retina Consultants of America, enhanced the company’s value to both pharmaceutical manufact",
    "url": "https://finance.yahoo.com/news/5-most-interesting-analyst-questions-053631014.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "f9d142f9-8ff6-350e-81d6-a355145da082",
      "content": {
        "id": "f9d142f9-8ff6-350e-81d6-a355145da082",
        "contentType": "STORY",
        "title": "The 5 Most Interesting Analyst Questions From Cencora’s Q3 Earnings Call",
        "description": "",
        "summary": "Cencora’s third quarter saw a positive market response, as the company delivered revenue and non-GAAP earnings that exceeded Wall Street expectations. Management pointed to strong growth in its U.S. Healthcare Solutions segment and the contribution of specialty pharmaceuticals as key drivers. CEO Robert Mauch emphasized that investments in areas like specialty distribution and recent acquisitions, such as Retina Consultants of America, enhanced the company’s value to both pharmaceutical manufact",
        "pubDate": "2025-11-12T05:36:31Z",
        "displayTime": "2025-11-12T05:36:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/f723825adbb97979db9b230de11d272e",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "COR Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oAi.6jIleJYmFGTOMbJfpA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/f723825adbb97979db9b230de11d272e.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9M45p4o9yNmk6TmYAMagCQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/f723825adbb97979db9b230de11d272e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-most-interesting-analyst-questions-053631014.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-most-interesting-analyst-questions-053631014.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]